Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Sun, Ming ^a   Liu, Xiang Hua ^a   Wang, Ke Ming ^b   Nie, Feng qi ^a   Kong, Rong ^a   Yang, Jin song ^c   Xia, Rui ^a   Xu, Tong Peng ^a   Jin, Fei Yan ^a   Liu, Zhi Jun ^a   Chen, Jin fei ^c   Zhang, Er Bao ^a   De, Wei ^a   Wang, Zhao Xia ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE ACTIVATED NON CODING RNA; GELATINASE A; HISTONE; LONG UNTRANSLATED RNA; NERVE CELL ADHESION MOLECULE; PROTEIN; SIP1 PROTEIN; SNAIL1 PROTEIN; SNAIL2 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL VIABILITY; DEACETYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84899157532     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-68     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
2. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?. Br J Cancer 2009, 101(Suppl 2):S102-S109. 2790714, 19956153.
3. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009, 9:274-284. 10.1038/nrc2622, 19308067.
4. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007, 7:737-749. 10.1038/nrc2229, 17891189.
5. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009, 28:15-33. 10.1007/s10555-008-9169-0, 19169796.
6. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374. 10.1038/nrc1075, 12724734.
7. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890. 10.1016/j.cell.2009.11.007, 19945376.
8. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 2012, 72:4883-4889. 10.1158/0008-5472.CAN-12-1223, 3649848, 23002209.
9. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009, 119:1438-1449. 10.1172/JCI38019, 2689100, 19487820.
10. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392:190-193. 10.1038/32433, 9515965.
11. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981. 10.1083/jcb.200601018, 2063755, 16567498.
12. Cano A, Nieto MA. Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol 2008, 18:357-359. 10.1016/j.tcb.2008.05.005, 18585040.
13. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012, 8:2289-2294. 10.1039/c2mb25070e, 22722759.
14. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010, 42:1113-1117. 10.1038/ng.710, 3040650, 21057500.
15. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419. 10.1016/j.cell.2010.06.040, 2956184, 20673990.
16. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10:155-159. 10.1038/nrg2521, 19188922.
17. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011, 71:3-7. 3057914, 21199792.
18. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011, 21:354-361. 10.1016/j.tcb.2011.04.001, 21550244.
19. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012, 31:4577-4587. 10.1038/onc.2011.621, 3433647, 22266873.
20. Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, Kretz M, Khavari PA. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res 2012, 22:1006-1014. 10.1101/gr.140061.112, 3371703, 22581800.
21. Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, Wang ZX, Cao XF, De W. MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1. Mol Cancer Ther 2012, 11:842-852. 10.1158/1535-7163.MCT-11-1015, 22343731.
22. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076. 10.1038/nature08975, 3049919, 20393566.
23. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko AS, Arun G, Stentrup M, Gross M, Zörnig M, MacLeod AR, Spector DL, Diederichs S. The non-coding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013, 73(3):1180-1189. 10.1158/0008-5472.CAN-12-2850, 3589741, 23243023.
24. Stanbridge EJ. Identifying tumor suppressor genes in human colorectal cancer. Science 1990, 247:12-13. 10.1126/science.2403692, 2403692.
25. Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet 2012, 81:303-311. 10.1111/j.1399-0004.2011.01809.x, 3590802, 22082348.
26. Benetatos L, Dasoula A, Hatzimichael E, Georgiou I, Syrrou M, Bourantas KL. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma 2008, 8:171-175. 10.3816/CLM.2008.n.021, 18650181.
27. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30:4750-4756. 10.1038/onc.2011.193, 21625215.
28. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, Sun SH. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013, 49:1083-1096. 10.1016/j.molcel.2013.01.010, 23395002.
29. Katsuno Y, Lamouille S, Derynck R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 2013, 25:76-84. 10.1097/CCO.0b013e32835b6371, 23197193.
30. Soltermann A. Epithelial-mesenchymal transition in non-small cell lung cancer. Pathologe 2012, 33(Suppl 2):311-317.
31. Zhao R, Wu Z, Zhou Q. Epithelial-mesenchymal transition and tumor metastasis. Zhongguo Fei Ai Za Zhi 2011, 14:620-624.
32. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279. 10.1016/j.cell.2004.07.011, 15294153.
33. Acloque H, Thiery JP, Nieto MA. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 2008, 9:322-326. 10.1038/embor.2008.30, 2288772, 18323854.
34. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002, 20:2417-2428. 10.1200/JCO.2002.08.159, 12011119.
35. Liu D, Huang C, Kameyama K, Hayashi E, Yamauchi A, Kobayashi S, Yokomise H. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg 2001, 71:949-954. discussion 954-945, 10.1016/S0003-4975(00)02545-5, 11269479.
36. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369. 10.1016/j.cell.2011.09.028, 3234495, 22000014.
37. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Gene Med 2010, 12:561-563. 10.1002/jgm.1473, 20607692.